Update of adjuvant therapy for malignant melanoma and carcinoma of the breast: whom do you believe?

L J Humphrey. Am Surg. 1980 Jan.

. 1980 Jan;46(1):20-3.

No abstract available

Similar articles

Breast cancer. Part 2: Management.
Carroll S. Carroll S. Prof Nurse. 1998 Aug;13(11):791-5; quiz 790. Prof Nurse. 1998. PMID: 9782995 Review.
Immediate reconstruction after neoadjuvant chemotherapy: effect on adjuvant treatment starting and survival.
Gouy S, Rouzier R, Missana MC, Atallah D, Youssef O, Barreau-Pouhaer L. Gouy S, et al. Ann Surg Oncol. 2005 Feb;12(2):161-6. doi: 10.1245/ASO.2005.04.003. Epub 2005 Feb 4. Ann Surg Oncol. 2005. PMID: 15827797
Decision making in surgery: management of symptomatic early breast carcinoma.
Thomas P. Thomas P. Br J Hosp Med. 1994 Mar 16-Apr 5;51(6):287-9. Br J Hosp Med. 1994. PMID: 8032564
Biologic distinctions and therapeutic implications of sarcomatoid metaplasia of epithelial carcinoma of the breast.
Gutman H, Pollock RE, Janjan NA, Johnston DA. Gutman H, et al. J Am Coll Surg. 1995 Feb;180(2):193-9. J Am Coll Surg. 1995. PMID: 7850054
[1st revision of the National Consensus on Breast Cancer Treatment].
Consenso Nacional sobre Tratamiento del Cáncer Mamario. Consenso Nacional sobre Tratamiento del Cáncer Mamario. Ginecol Obstet Mex. 2002 Jul;70:349-60. Ginecol Obstet Mex. 2002. PMID: 12221911 Review. Spanish. No abstract available.

Adjuvant chemotherapy of breast cancer: hope--reality--hazard?
Vorherr H. Vorherr H. Klin Wochenschr. 1984 Feb 15;62(4):149-61. doi: 10.1007/BF01731637. Klin Wochenschr. 1984. PMID: 6708398